Literature DB >> 12098761

Cloning and characterization of a novel human secretory protein: secretogranin III.

Yi-Ping Rong1, Feng Liu, Ling-Chun Zeng, Wei-Jun Ma, Dong-Zhi Wei, Ze-Guang Han.   

Abstract

We have cloned a new member of the granin family, termed human secretogranin III (SgIII), that encodes 468 amino acid residues. The human SgIII protein possesses an N-terminal signal peptide, seven dibasic sites, and the repeated DSTK sequences. These structure characteristics are similar to other members of secretogranin family. The human SgIII has homologous proteins in mouse, rat, and Xenopus laevis. Genomic organization shows the gene includes 12 coding exons spanning 39 kb of genomic DNA on the human chromosome 15. Human SgIII is expressed widely as showed in Northern blot and its cDNA hybridizes to 2.2 kb and 1.9 kb bands in many tissues, with two additional 4.5 kb and 3.3 kb bands in brain. Subcelluar localization and immunoblotting indicated SgIII was secreted out of cell through trans-Golgi network (TGN). SgIII may take effect in the biogenesis of secretory granules as a helper protein and be involved in the production or release of peptide hormones in the regulated secretory pathway.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12098761

Source DB:  PubMed          Journal:  Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai)        ISSN: 0582-9879


  4 in total

1.  Super-Obese Patient-Derived iPSC Hypothalamic Neurons Exhibit Obesogenic Signatures and Hormone Responses.

Authors:  Uthra Rajamani; Andrew R Gross; Brooke E Hjelm; Adolfo Sequeira; Marquis P Vawter; Jie Tang; Vineela Gangalapudi; Yizhou Wang; Allen M Andres; Roberta A Gottlieb; Dhruv Sareen
Journal:  Cell Stem Cell       Date:  2018-04-19       Impact factor: 24.633

2.  Tat-PTD-modified oncolytic adenovirus driven by the SCG3 promoter and ASH1 enhancer for neuroblastoma therapy.

Authors:  Chuan Jin; Di Yu; Matko Čančer; Berith Nilsson; Justyna Leja; Magnus Essand
Journal:  Hum Gene Ther       Date:  2013-08       Impact factor: 5.695

Review 3.  Secretogranin III: a diabetic retinopathy-selective angiogenic factor.

Authors:  Wei Li; Keith A Webster; Michelle E LeBlanc; Hong Tian
Journal:  Cell Mol Life Sci       Date:  2017-08-30       Impact factor: 9.261

4.  Secretogranin III as a disease-associated ligand for antiangiogenic therapy of diabetic retinopathy.

Authors:  Michelle E LeBlanc; Weiwen Wang; Xiuping Chen; Nora B Caberoy; Feiye Guo; Chen Shen; Yanli Ji; Hong Tian; Hui Wang; Rui Chen; Wei Li
Journal:  J Exp Med       Date:  2017-03-22       Impact factor: 14.307

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.